Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) EBIT (2018 - 2025)

Verastem has reported EBIT over the past 8 years, most recently at -$41.5 million for Q4 2025.

  • Quarterly results put EBIT at -$41.5 million for Q4 2025, down 31.29% from a year ago — trailing twelve months through Dec 2025 was -$170.1 million (down 47.99% YoY), and the annual figure for FY2025 was -$170.1 million, down 47.99%.
  • EBIT for Q4 2025 was -$41.5 million at Verastem, down from -$40.7 million in the prior quarter.
  • Over the last five years, EBIT for VSTM hit a ceiling of -$14.1 million in Q1 2021 and a floor of -$44.2 million in Q1 2025.
  • Median EBIT over the past 5 years was -$20.8 million (2023), compared with a mean of -$25.6 million.
  • Peak annual rise in EBIT hit 46.48% in 2021, while the deepest fall reached 198.86% in 2021.
  • Verastem's EBIT stood at -$16.5 million in 2021, then decreased by 2.03% to -$16.8 million in 2022, then tumbled by 84.85% to -$31.1 million in 2023, then fell by 1.45% to -$31.6 million in 2024, then plummeted by 31.29% to -$41.5 million in 2025.
  • The last three reported values for EBIT were -$41.5 million (Q4 2025), -$40.7 million (Q3 2025), and -$43.8 million (Q2 2025) per Business Quant data.